Prescription Medicines Code of Practice Authority (PMCPA)
Some plans may cover these treatments when prescribed for a qualifying diagnosis, such as obesity (BMI 30) or overweight (BMI 27) with a weight-related comorbidity
In one of the focus groups, there was no disagreement when one participant asked, [d]oes it feel almost inevitable that those drugs are going to become part of our formulary? Our insurance provider, Cigna told us that within the next 9 to 12 months, theres really not going to be a choice, that all insurance companies are probably going to be covering GLP-1s for weight loss. Occupational health manager, large manufacturer The use of GLP-1 drugs for weight loss is still new for many employers, and many are not sure how or whether they can manage the benefit
However, its still crucial to be aware of how other factors, such as liver and kidney health or additional medications, might influence your experience with these drugs
Typically, Semaglutide GLP-1 injections are recommended for individuals with a BMI of 30 or higher, or 27 or higher with weight-related health conditions
